For example, AstraZeneca (AZ) has recently signed an exclusive license agreement with Eccogene granting it certain exclusive global rights for Eccogenes oral GLP-1RA drug in development
Weight changes from GLP-1 therapy may require adjustment of levothyroxine doses, necessitating close thyroid function monitoring
For bulk orders and academic pricing, contact our team.
The field of, youre right, diabetes and so on, I think really took notice especially when the weight loss effects were being seen
People who are pregnant, breastfeeding, or planning pregnancy should avoid retatrutide, along with those who have a personal or family history of thyroid cancer or previous pancreatitis
Lori Suet Hang 1 , Richard Sawatzky 2 , Joanne Greenhalgh 3 , Kara Schick-Makaroff 4 1 Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada, 2 School of Nursing, Trinity Western University, Vancouver, British Columbia, Canada, 3 School of Sociology and Social Policy, University of Leeds, Leeds, UK, 4 Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :VP17 Aims People receiving dialysis commonly experience anxiety symptoms and low quality of life, yet the problem remains under-addressed